BriefCase-Triage vs ClearRead CT
AI Verdict
Choose BriefCase-Triage if…
Choose BriefCase-Triage if your health system requires a comprehensive, enterprise-level AI solution to rapidly detect and prioritize a wide range of critical findings across various medical imaging modalities. This tool is ideal for organizations focused on improving overall radiology workflow efficiency and ensuring timely intervention for urgent cases through real-time alerts and mobile care coordination.
View BriefCase-Triage →Choose ClearRead CT if…
Choose ClearRead CT if your practice specializes in cardiothoracic imaging and needs highly accurate AI for detailed analysis of pulmonary nodules and coronary artery calcification in CT scans. This solution is particularly well-suited for improving diagnostic accuracy, reducing reading times, and tracking changes in specific thoracic conditions, especially where vessel suppression and precise nodule characterization are paramount.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | BriefCase-Triage | ClearRead CT |
|---|---|---|
| Pricing | Enterprise pricing starts at approximately $50,000 per site per year. | Contact for pricing |
| Deployment | Cloud-based. Aidoc's platform runs on AWS and Azure. The deployment process is described as lightweight, straightforward, and can be up and running in 2 to 3 weeks with minimal effort from facility IT. | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
| EHR Integration | Epic | Not specified |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
BriefCase-TriageBriefCase-Triage (Tool A) offers seamless integration with both PACS and EHR systems, and includes a mobile app for care coordination. This provides a broader and more flexible user experience compared to ClearRead CT (Tool B), which primarily highlights PACS integration. The mobile app enhances accessibility and workflow beyond the traditional workstation.
Clinical Value
BriefCase-TriageBriefCase-Triage (Tool A) provides a comprehensive triage solution across multiple indications and specialties, aiming for an 'order-of-magnitude reduction in false alerts.' While ClearRead CT (Tool B) offers impressive, specific metrics for pulmonary nodule detection and CAC scoring, Tool A's broader impact on prioritizing critical findings across diverse medical images offers greater overall clinical value for a general hospital setting.
Pricing & Value
BriefCase-TriageBriefCase-Triage (Tool A) offers more transparent pricing details, including annual or multi-year upfront discounts and flexible monthly or quarterly payment options via Capchase. ClearRead CT (Tool B) only states 'contact for pricing' without any further details on payment flexibility or potential discounts. This transparency and flexibility from Tool A can offer better value propositions for organizations.
Enterprise Readiness
BriefCase-TriageBriefCase-Triage (Tool A) explicitly states HIPAA, SOC2, and GDPR compliance, and has a proven track record with over 1,600 hospitals worldwide. ClearRead CT (Tool B) has less definitive compliance claims ('likely, contact vendor for details') and does not provide a customer count. Tool A's clear certifications and extensive customer base demonstrate stronger enterprise readiness and trust.
Innovation
ClearRead CTClearRead CT (Tool B) features 'patented Vessel Suppression (Clear Visual Intelligence)' and automated nodule tracking and comparison to prior exams, which are distinct and specialized technological innovations within its domain. While BriefCase-Triage (Tool A) offers a 'continuous learning model' and comprehensive triage, Tool B's patented core technology for image enhancement and specific nodule analysis stands out as a unique innovative differentiator.
Support & Docs
TieNeither the provided structured facts nor general web searches offer sufficient specific details regarding the support structures, documentation availability, or service level agreements for either BriefCase-Triage (Tool A) or ClearRead CT (Tool B). Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | BriefCase-Triage | ClearRead CT |
|---|---|---|
| Name | BriefCase-Triage | ClearRead CT |
| Company | Aidoc Medical | RIVERAIN TECHNOLOGIES |
| Description | FDA-cleared AI solution for physicians, enhancing radiology workflows by rapidly detecting and prioritizing critical findings in medical images. | FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology. |
| Categories | Cardiology AI, Clinical Decision Support & Reference, Radiology & Imaging AI | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Emergency Medicine, General Surgery, Neurology, Oncology, Radiology | Cardiology, Pulmonology, Radiology |
| Key Features | AI-powered analysis of medical imaging, Real-time alerts and notifications, Seamless integration with existing hospital systems (PACS, EHR), Prioritization of critical cases, Order-of-magnitude reduction in false alerts, Comprehensive triage solution (multiple indications in one workflow), Mobile app for care coordination, Continuous learning model | Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement (volume, diameter, location, type, depth), Automated Nodule Tracking and Comparison to Prior Exams, Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs), Reduced Reading Time (up to 36%), Improved Detection Accuracy (29% reduction in missed actionable nodules), Seamless PACS Integration / Vendor-neutral processing |
Videos
Demos, reviews, and walkthroughs featuring BriefCase-Triage and ClearRead CT.
Frequently Asked Questions
More Comparisons
More matchups featuring BriefCase-Triage or ClearRead CT
Backers
Who funded each tool's parent company.